Article Information
History
- March 1, 2023.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Cassandra Laurie, MSc1,
- Mariam El-Zein, PhD1,
- Sarah Botting-Provost, MSc1,
- Joseph E. Tota, PhD2,
- Pierre-Paul Tellier, MD3,
- François Coutlée, MD4,
- Ann N. Burchell, PhD5 and
- Prof Eduardo L. Franco, DrPH1,*
- 1Division of Cancer Epidemiology, McGill University, Montreal, Canada
- 2Epidemiology Department, Merck & Co. Inc., Rahway, NJ, USA
- 3Department of Family Medicine, McGill University, Montreal, Canada
- 4Laboratoire de virologie moléculaire, Centre de recherche, Centre hospitalier de l’Université de Montréal (CRCHUM), et Département de Microbiologie, infectiologie et Immunologie, Université de Montréal, Montréal, Canada
- 5Department of Family and Community Medicine and MAP Centre for Urban Health Solutions, Li Ka Shing Knowledge Institute, St. Michael’s Hospital, Unity Health Toronto, Toronto, Canada
- ↵*Correspondence to: Prof. Eduardo L Franco, Department of Oncology, McGill University, Montreal H4A 3T2, Canada, eduardo.franco{at}mcgill.ca
Posted March 01, 2023.
Self-applied carrageenan-based gel to prevent human papillomavirus infection in sexually active young women: Final analysis of efficacy and safety of a randomised controlled trial
